494
Participants
Start Date
October 9, 2017
Primary Completion Date
December 28, 2021
Study Completion Date
December 28, 2021
Foster 100/6mg NEXThaler
Fixed combination of beclomethasone dipropionate 100mg plus formoterol fumarate 6mg per actuation as inhalation powder with a new dry powder inhaler
Foster 100/6mg pMDI
Fixed combination of beclomethasone dipropionate 100mg plus formoterol fumarate 6mg per actuation as pMDI with HFA\_134a propellant
Chiesi Clinical Trial site 15682, Beijing
Chiesi Clinical Trial site 15672, Beijing
Chiesi Clinical Trial site 15663, Beijing
Chiesi Clinical Trial site 15676, Jilin
Chiesi Clinical Trial site 15678, Qiqihar
Chiesi Clinical Trial site 15630, Shanghai
Chiesi Clinical Trial site 15664, Shanghai
Chiesi Clinical Trial site 15654, Shanghai
Chiesi Clinical Trial site 15643, Changzhou
Chiesi Clinical Trial site 15642, Tianjin
Chiesi Clinical Trial site 15634, Tianjin
Chiesi clinical Trial site 15619, Nanchang
Chiesi Clinical Trial site 15674, Pingxiang
Chiesi Clinical Trial site 15680, Chongqing
Chiesi Clinical Trial site 15675, Hengyang
Chiesi Clinical Trial site 15614, Wuhan
Chiesi Clinical Trial site 15679, Zhengzhou
Chiesi Clinical Trial site 15681, Xinxiang
Chiesi clinical Trial Site 15610, Guangzhou
Chiesi Clinical Trial site 15610, Guangzhou
Chiesi Clinical Trial site 15668, Guangzhou
Chiesi Clinical Trial site 15677, Huizhou
Chiesi Clinical Trial site 15683, Shenzhen
Chiesi Clinical Trial site 15607, Zhanjiang
Chiesi Clinical Trial site 15673, Haikou
Chiesi Clinical Trial site 15633, Chengdu
Chiesi Clinical Trial site 15626, Xi'an
Chiesi Clinical Trial site 15669, Ürümqi
Chiesi Clinical Trial site 15671, Guangzhou
Chiesi Clinical Trial site 15641, Hefei
Chiesi Clinical Trial site 15662, Foshan
Chiesi clinical Trial site 15656, Guangzhou
Chiesi Clinical Trial site 15668, Guangzhou
Chiesi Clinical Trial site 15608, Shenzhen
Chiesi Clinical Trial site 15661, Wuhan
Chiesi clinical Trial site 15621, Shenyang
Chiesi clinical Trial site 15659, Hohhot
Chiesi Clinical Trial site 15630, Shanghai
Chiesi Clinical Trial site 15631, Shanghai
Chiesi Clinical Trial site 15665, Shanghai
Chiesi clinical Trial site 15636, Beijing
Chiesi Clinical Trial site 15638, Chongqing
Chiesi Clinical Trial site 15670, Guizhou
Chiesi clinical Trial Site 15611, Hebei
Chiesi Clinical trial site 15660, Jilin
Chiesi Clinical Trial site 15628, Shanghai
Chiesi clinical trial site 15637, Shanghai
Chiesi Clinical Trial site 15666, Shenzhen
Chiesi clinical Trial site 15633, Sichuan
Chiesi Clinical Trial site 15650, Hohhot
Chiesi Clinical Trial site 15625, Taiyuan
Chiesi Clinical Trial site 15611, Shijiazhuang
Chiesi Farmaceutici S.p.A.
INDUSTRY